{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:04:05Z","timestamp":1792087445818,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T00:00:00Z","timestamp":1298505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s10096-011-1197-y","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T01:03:49Z","timestamp":1298423029000},"page":"1095-1103","source":"Crossref","is-referenced-by-count":27,"title":["Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany"],"prefix":"10.1007","volume":"30","author":[{"name":"Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kresken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"K\u00f6rber-Irrgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-A.","family":"L\u00f6schmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,24]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1086\/319235","volume":"32","author":"AS Fauci","year":"2001","unstructured":"Fauci AS (2001) Infectious diseases: considerations for the 21st century. Clin Infect Dis 32:675\u2013685","journal-title":"Clin Infect Dis"},{"key":"1197_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.281.1.61","volume":"281","author":"GL Armstrong","year":"1999","unstructured":"Armstrong GL, Conn LA, Pinner RW (1999) Trends in infectious disease mortality in the United States during the 20th century. JAMA 281:61\u201366","journal-title":"JAMA"},{"key":"1197_CR3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/35021206","volume":"406","author":"ML Cohen","year":"2000","unstructured":"Cohen ML (2000) Changing patterns of infectious disease. Nature 406:762\u2013767","journal-title":"Nature"},{"key":"1197_CR4","unstructured":"Bundesministerium f\u00fcr Gesundheit, Bundesministerium f\u00fcr Ern\u00e4hrung, Landwirtschaft und Verbraucherschutz, und Bundesministerium f\u00fcr Bildung und Forschung (2008) DART\u2014Deutsche Antibiotika-Resistenzstrategie"},{"issue":"Suppl 4","key":"1197_CR5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.3949\/ccjm.74.Suppl_4.S12","volume":"74","author":"LB Rice","year":"2007","unstructured":"Rice LB (2007) Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria. Cleve Clin J Med 74(Suppl 4):S12\u2013S20","journal-title":"Cleve Clin J Med"},{"key":"1197_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1615\/CritRevImmunol.v30.i1.60","volume":"30","author":"TD Gootz","year":"2010","unstructured":"Gootz TD (2010) The global problem of antibiotic resistance. Crit Rev Immunol 30:79\u201393","journal-title":"Crit Rev Immunol"},{"key":"1197_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jinf.2006.05.014","volume":"53","author":"AP Fraise","year":"2006","unstructured":"Fraise AP (2006) Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? J Infect 53:293\u2013300","journal-title":"J Infect"},{"key":"1197_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0029-1202935","volume":"30","author":"F Rodr\u00edguez de Castro","year":"2009","unstructured":"Rodr\u00edguez de Castro F, Naranjo OR, Marco JA, Viol\u00e1n JS (2009) New antimicrobial molecules and new antibiotic strategies. Semin Respir Crit Care Med 30:161\u2013171","journal-title":"Semin Respir Crit Care Med"},{"issue":"Suppl 6","key":"1197_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-0691.2008.02125.x","volume":"14","author":"LR Peterson","year":"2008","unstructured":"Peterson LR (2008) Currently available antimicrobial agents and their potential for use as monotherapy. Clin Microbiol Infect 14(Suppl 6):30\u201345","journal-title":"Clin Microbiol Infect"},{"key":"1197_CR10","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/dkn311","volume":"62","author":"T Kelesidis","year":"2008","unstructured":"Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME (2008) Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62:895\u2013904","journal-title":"J Antimicrob Chemother"},{"key":"1197_CR11","unstructured":"European Antimicrobial Resistance Surveillance System (EARSS) (2009) EARSS Annual Report 2008"},{"key":"1197_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2004.03.002","volume":"49","author":"TR Fritsche","year":"2004","unstructured":"Fritsche TR, Kirby JT, Jones RN (2004) In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections. Diagn Microbiol Infect Dis 49:201\u2013209","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1197_CR13","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1128\/AAC.49.4.1636-1638.2005","volume":"49","author":"AC Fluit","year":"2005","unstructured":"Fluit AC, Florijn A, Verhoef J, Milatovic D (2005) Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline. Antimicrob Agents Chemother 49:1636\u20131638","journal-title":"Antimicrob Agents Chemother"},{"key":"1197_CR14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.47.3.972-978.2003","volume":"47","author":"CR Dean","year":"2003","unstructured":"Dean CR, Visalli MA, Projan SJ, Sum PE, Bradford PA (2003) Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 47:972\u2013978","journal-title":"Antimicrob Agents Chemother"},{"key":"1197_CR15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.47.2.665-669.2003","volume":"47","author":"MA Visalli","year":"2003","unstructured":"Visalli MA, Murphy E, Projan SJ, Bradford PA (2003) AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob Agents Chemother 47:665\u2013669","journal-title":"Antimicrob Agents Chemother"},{"key":"1197_CR16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jac\/dkm397","volume":"61","author":"D Keeney","year":"2008","unstructured":"Keeney D, Ruzin A, McAleese F, Murphy E, Bradford PA (2008) MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 61:46\u201353","journal-title":"J Antimicrob Chemother"},{"key":"1197_CR17","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AAC.49.5.1865-1871.2005","volume":"49","author":"F McAleese","year":"2005","unstructured":"McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ, Bradford PA (2005) A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother 49:1865\u20131871","journal-title":"Antimicrob Agents Chemother"},{"key":"1197_CR18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/AAC.49.3.1017-1022.2005","volume":"49","author":"A Ruzin","year":"2005","unstructured":"Ruzin A, Visalli MA, Keeney D, Bradford PA (2005) Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother 49:1017\u20131022","journal-title":"Antimicrob Agents Chemother"},{"key":"1197_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10096-008-0589-0","volume":"28","author":"M Kresken","year":"2009","unstructured":"Kresken M, Leitner E, Brauers J, Geiss HK, Halle E, von Eiff C, Peters G, Seifert H (2009) Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in Germany. Eur J Clin Microbiol Infect Dis 28:83\u201390","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1197_CR20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10096-009-0725-5","volume":"28","author":"M Kresken","year":"2009","unstructured":"Kresken M, Leitner E, Seifert H, Peters G, von Eiff C (2009) Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007). Eur J Clin Microbiol Infect Dis 28:1007\u20131011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1197_CR21","unstructured":"Deutsches Institut f\u00fcr Normung (DIN) (2006) Labormedizinische Untersuchungen und In-vitro-Diagnostika-Systeme\u2014Empfindlichkeitspr\u00fcfung von Infektionserregern und Evaluation von Ger\u00e4ten zur antimikrobiellen Empfindlichkeitspr\u00fcfung, Teil 1: Referenzmethode zur Testung der In-vitro-Aktivit\u00e4t von antimikrobiellen Substanzen gegen schnell wachsende aerobe Bakterien, die Infektionskrankheiten verursachen (ISO 20776\u20131:2006). Beuth-Verlag, Berlin"},{"key":"1197_CR22","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2010) Breakpoint tables for interpretation of MICs and zone diameters. Version 1.1 April 2010"},{"key":"1197_CR23","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. CLSI document M100-S19","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2009) Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. CLSI document M100-S19. CLSI, Wayne, PA"},{"key":"1197_CR24","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement (M100-S18)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008) Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement (M100-S18). CLSI, Wayne, PA"},{"key":"1197_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.diagmicrobio.2009.09.012","volume":"66","author":"J Papaparaskevas","year":"2010","unstructured":"Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ (2010) In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn Microbiol Infect Dis 66:187\u2013194","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1197_CR26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1179\/joc.2009.21.2.144","volume":"21","author":"C Bantar","year":"2009","unstructured":"Bantar C, Curcio D, Fernandez Canigia L, Garc\u00eda P, Guzm\u00e1n Blanco M, Leal AL (2009) Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America. J Chemother 21:144\u2013152","journal-title":"J Chemother"},{"key":"1197_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2010.04.002","volume":"68","author":"YF Wang","year":"2010","unstructured":"Wang YF, Dowzicky MJ (2010) In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Diagn Microbiol Infect Dis 68:73\u201379","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1197_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diagmicrobio.2007.06.004","volume":"59","author":"RN Jones","year":"2007","unstructured":"Jones RN, Fritsche TR, Sader HS, Ross JE (2007) LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn Microbiol Infect Dis 59:309\u2013317","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1197_CR29","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1128\/AAC.00131-06","volume":"50","author":"KS Long","year":"2006","unstructured":"Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B (2006) The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 50:2500\u20132505","journal-title":"Antimicrob Agents Chemother"},{"key":"1197_CR30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/650574","volume":"50","author":"G Morales","year":"2010","unstructured":"Morales G, Picazo JJ, Baos E, Candel FJ, Arribi A, Pel\u00e1ez B, Andrade R, de la Torre MA, Fereres J, S\u00e1nchez-Garc\u00eda M (2010) Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 50:821\u2013825","journal-title":"Clin Infect Dis"},{"key":"1197_CR31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/656281","volume":"51","author":"H Bonilla","year":"2010","unstructured":"Bonilla H, Huband MD, Seidel J, Schmidt H, Lescoe M, McCurdy SP, Lemmon MM, Brennan LA, Tait-Kamradt A, Puzniak L, Quinn JP (2010) Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin Infect Dis 51:796\u2013800","journal-title":"Clin Infect Dis"},{"key":"1197_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/503046","volume":"194","author":"E Lautenbach","year":"2006","unstructured":"Lautenbach E, Fishman NO, Metlay JP, Mao X, Bilker WB, Tolomeo P, Nachamkin I (2006) Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis 194:79\u201385","journal-title":"J Infect Dis"},{"key":"1197_CR33","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/379709","volume":"37","author":"MJ Zervos","year":"2003","unstructured":"Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, Donnelly AJ, Eckel SF, Eng RH, Hiltz A, Kuyumjian AG, Krebs W, McDaniel A, Hogan P, Lubowski TJ (2003) Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991\u20132000. Clin Infect Dis 37:1643\u20131648","journal-title":"Clin Infect Dis"},{"key":"1197_CR34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2334-8-4","volume":"8","author":"LB Boyd","year":"2008","unstructured":"Boyd LB, Atmar RL, Randall GL, Hamill RJ, Steffen D, Zechiedrich L (2008) Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis 8:4","journal-title":"BMC Infect Dis"},{"key":"1197_CR35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhin.2009.12.007","volume":"75","author":"E Protonotariou","year":"2010","unstructured":"Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A (2010) Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect 75:225\u2013227","journal-title":"J Hosp Infect"},{"key":"1197_CR36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/00365540701472064","volume":"39","author":"C Claesson","year":"2007","unstructured":"Claesson C, H\u00e4llgren A, Nilsson M, Svensson E, Hanberger H, Nilsson LE (2007) Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countries. Scand J Infect Dis 39:1002\u20131012","journal-title":"Scand J Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1197-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1197-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1197-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:34:24Z","timestamp":1559108064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1197-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,24]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1197-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,24]]}}}